Register today!

Register for the Conference

Saturday, August 22, 2026,
8:30 a.m. – 4:15 p.m.

Health Education Building
University of Kansas Medical Center
Kansas City, KS

View the Agenda

This program brings together leading experts in regenerative medicine and cellular immunotherapy to explore the rapidly evolving science and clinical translation of mesenchymal stromal cells, extracellular vesicles and engineered T-cell therapies. Participants will gain practical insights into current challenges and future directions in immune modulation and cell-based therapeutics.

The program highlights translational considerations across cell therapy platforms, from mesenchyal stromal cell-and extracellular vesicle- based therapies to next-generation immune engineering strategies including tumor-infiltrating lymphocytes, bispecific T-cell engagers and chimeric antigen receptor T-cell therapies across oncology and autoimmune disease.

CALL FOR ABSTRACTS

Course Director:

Exhibit at the Conference

EXHIBITOR OPPORTUNITIES

Target audience

This conference is designed for a specialized, professional audience working at the intersection of translational science and clinical application of cellular therapies, including: clinicians involved in the use or referral of cellular therapies; Hematologists/oncologists, Immunologists, Rheumatologists, Transplant and cellular therapy physicians; physician-scientists and translational researchers focused on MSCs, EVs, and engineered T‑cell platforms; and cell and gene therapy investigators.

Special thanks to our industry partners for supporting our educational outreach efforts and helping make this conference possible.